Patents by Inventor Kelvin K. Ogilvie

Kelvin K. Ogilvie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5157120
    Abstract: Nucleoside analogues having a ring-open structure, of general formula: ##STR1## where R and R' may be hydrogen, silyl groups, substituted alkyl groups, benzyl groups and the like, and X is an optionally substituted base such as guanine or adenine, have been shown to exhibit anti-viral and other biological activities at non-toxic levels.
    Type: Grant
    Filed: September 16, 1981
    Date of Patent: October 20, 1992
    Assignee: Syntex (U.S.A.) Inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 5100456
    Abstract: The invention relates to the isolation, characterization and application of a bioherbicide composition characterized by its phytotoxcity towards the agricultural pest Convolvulus arvensis (field bindweed) and the aquatic weed Lemna paucicostata. The composition consists of a compound of formula I: ##STR1## wherein R.sub.1 is selected from H and OH, and R.sub.2 is selected from --CH.sub.2 OH and --COOH, salts and esters thereof, in association with an agriculturally acceptable carrier. The herbicide of this invention can be used for the control of field binweed and potentially other pest plants.
    Type: Grant
    Filed: July 12, 1990
    Date of Patent: March 31, 1992
    Assignee: Royal Institution for the Advancement of Learning (McGill University)
    Inventors: Youla S. Tsantrizos, Kelvin K. Ogilvie, Alan K. Watson
  • Patent number: 5004754
    Abstract: The invention relates to a biofungicidal composition characterized by its capacity to arrest the growth and/or destroy the cell wall of pathogenic fungi, comprises a composition of a compound of the formula I ##STR1## wherein R.sub.1 is selected from the group consisting of ##STR2## and R.sub.2 is --H or --OH and mixtures thereof in association with an inert carrier, and to a method for arresting the growth and/or destroying the cell wall of pathogenic fungi by applying thereto a biofungicidal amount of the composition of a compound of formula I in association with an inert carrier.
    Type: Grant
    Filed: June 5, 1989
    Date of Patent: April 2, 1991
    Assignee: Universite Laval
    Inventors: J. Andre Fortin, Kelvin K. Ogilvie, Youla S. Tsantrizos, Harry H. Kope
  • Patent number: 4868187
    Abstract: Nucleoside analogues having a ring-open structure, of general formula: ##STR1## where R and R' may be hydrogen, silyl groups, substituted alkyl groups, benzyl groups and the like, and X is an optionally substituted base such as guanine or adenine, have been shown to exhibit anti-viral and other biological acivities at non-toxic levels.
    Type: Grant
    Filed: March 9, 1987
    Date of Patent: September 19, 1989
    Assignee: Syntex (U.S.A.) Inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4508898
    Abstract: Compounds to general formula ##STR1## in which R and R' are hydrogen or benzyl and X represents a purine on pyrimidine base group selected from isoguanine, guanine, cytosine, 5-fluorouracil, S-methyl uracil (thymine) and chloroguanine, exhibit anti-viral properties.
    Type: Grant
    Filed: June 8, 1982
    Date of Patent: April 2, 1985
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4501744
    Abstract: Nucleoside analogues having a ring-open structure, of general formula: ##STR1## where R and R' may be hydrogen, silyl groups, substituted alkyl groups, benzyl groups and the like, and X is an optionally substituted pyrimidine or triazine base, exhibit anti-viral activities e.g. against herpes simplex virus and cytomegalo-virus at non-toxic levels.
    Type: Grant
    Filed: July 28, 1983
    Date of Patent: February 26, 1985
    Assignee: ens BIO LOGICALS Inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4461757
    Abstract: 2-(N,N-dialkylaminomethylene)-9-[[2-hydroxy-1-(hydroxymethyl)-ethoxy]methyl ]guanine either alone or in admixture with interferon is active in treatment of herpes simplex type 1 viral infections.
    Type: Grant
    Filed: February 23, 1983
    Date of Patent: July 24, 1984
    Assignee: ens Bio Logicals Inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4460690
    Abstract: The novel nucleoside analogue 9-[1-(1,3-diacetoxy-2-propoxy)-2-acetoxy]ethylguanine has the effect of stimulating the rate of growth of certain viruses, particularly influenza viruses, so that culturing virally infected cells in the presence of this compound substantially decreases the time required for diagnosis and typing of the virus, ready for administration of appropriate anti viral measures.
    Type: Grant
    Filed: February 18, 1983
    Date of Patent: July 17, 1984
    Assignee: ens Bio Logicals inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4404368
    Abstract: Phosphorylated nucleotides for addition to nucleotide chains in the stepwise synthesis of oligonucleotides, e.g. as a polymeric support, are prepared in dioxane solvent and then lyophilized, to provide a stable, dry product ready for re-dissolving in reaction solvent. The lyophilized products are stable indefinitely and do not suffer from decreased reactivity.
    Type: Grant
    Filed: February 17, 1981
    Date of Patent: September 13, 1983
    Inventors: Gabriel G. Alvarado-Urbina, Kelvin K. Ogilvie
  • Patent number: 4347360
    Abstract: Nucleoside analogues having a ring-open structure, of general formula: ##STR1## where R and R' may be hydrogen, silyl groups, substituted alkyl groups and the like, and B is a base such as adenine, have been shown to exhibit anti-viral and other biological activities at non-toxic levels. Also provided are phosphate-linked dinucleotide compounds of similar structures.
    Type: Grant
    Filed: September 16, 1980
    Date of Patent: August 31, 1982
    Assignee: ens BIO LOGICALS Inc.
    Inventor: Kelvin K. Ogilvie
  • Patent number: 4334059
    Abstract: Silylated arabino-base compounds of the general formula: ##STR1## in which B represents an optionally substituted purine or pyrimidine base (cytosine, guanine, uracil, thymine or adenine) and one at least of R, R' and R" is alkylsilyl, the others being hydrogen, show activity as antiviral agents, especially in combatting herpes simplex virus. The preferred alkylsilyl group is tert. butyldimethylsilyl.
    Type: Grant
    Filed: October 20, 1980
    Date of Patent: June 8, 1982
    Assignee: Bio Logicals Inc.
    Inventor: Kelvin K. Ogilvie